Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Doximity (DOCS)
NYSE:DOCS
DOCS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$22.96 - $85.21
Previous CloseN/A
Volume296.07K
Average Volume (3M)2.50M
Market Cap
$14.62B
Enterprise Value$9.97B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)76.5
Beta1.74
Next Earnings
May 20, 2025EPS Estimate
0.27Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.00
Shares Outstanding133,502,330
10 Day Avg. Volume4,473,359
30 Day Avg. Volume2,502,389
Standard Deviation0.17
R-Squared0.15
Alpha0.00173
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)26.15
Price to Cash Flow (P/CF)55.20
P/FCF Ratio55.20
Enterprise Value/Market Cap0.68
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit23.46
Enterprise Value/Ebitda46.93
Forecast
1Y Price Target
$72.50Price Target Upside-3.33% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering18
---
Doximity News
---
Bulls Say, Bears Say
Bulls Say
Customer GrowthThe number of customers spending over $500K annually has increased, highlighting strong demand for DOCS' offerings and the company's ability to attract and retain high-value clients.
Product ExpansionNewer products like Point of Care and Formulary are experiencing significant growth, contributing to 20% of new sales, showcasing the success of DOCS' product diversification strategy.
ProfitabilityDOCS is demonstrating strong profitability with a remarkable sequential incremental EBITDA margin of 81%, emphasizing the company's ability to generate significant profit from additional revenue.
Bears Say
Growth NormalizationNext year, growth is expected to normalize to about 2x the market rate, which is in line with the past 4 years, suggesting a potential slowdown compared to the current growth rate.
Revenue Growth4Q implied revenue growth of 13% at midpoint and adj-EBITDA margin of 47.4% is a step-down from the last two quarter levels, indicating potential normalization in growth momentum.
Revenue GuidanceThere is an element of conservatism in the FY4Q'25 guidance, with expected year-over-year revenue growth of roughly 11%, indicating a more cautious outlook on future growth prospects.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
DOCS FAQ
What was Doximity’s price range in the past 12 months?
Doximity lowest stock price was $22.96 and its highest was $85.21 in the past 12 months.
What is Doximity’s market cap?
Doximity’s market cap is $14.62B.
When is Doximity’s upcoming earnings report date?
Doximity’s upcoming earnings report date is May 20, 2025 which is in 87 days.
How were Doximity’s earnings last quarter?
Doximity released its earnings results on Feb 06, 2025. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.337 by $0.113.
Is Doximity overvalued?
According to Wall Street analysts Doximity’s price is currently Overvalued.
Does Doximity pay dividends?
Doximity does not currently pay dividends.
What is Doximity’s EPS estimate?
Doximity’s EPS estimate is 0.27.
How many shares outstanding does Doximity have?
Doximity has 133,502,330 shares outstanding.
What happened to Doximity’s price movement after its last earnings report?
Doximity reported an EPS of $0.45 in its last earnings report, beating expectations of $0.337. Following the earnings report the stock price went up 35.994%.
Which hedge fund is a major shareholder of Doximity?
Currently, no hedge funds are holding shares in DOCS
---
Doximity Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$72.50 (-3.33% Downside)
$72.50 (-3.33% Downside)
Blogger Sentiment
Bullish
DOCS Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 9.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $79.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.9%
Last 30 Days ▲ 28.5%
Last 30 Days ▲ 28.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
155.10%
12-Months-Change
Fundamentals
Return on Equity
21.24%
Trailing 12-Months
Asset Growth
17.14%
Trailing 12-Months
Company Description
Doximity
Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.
---
DOCS Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong performance with significant revenue and EBITDA growth, driven by high client retention and successful new product launches. However, potential challenges include dependency on integrated programs and tougher future revenue comparisons.Read More>---
DOCS Revenue Breakdown
93.00% Subscription
7.00% Other
---
DOCS Stock 12 Month Forecast
Average Price Target
$72.50
▼(-3.33% Downside)
Technical Analysis
Best Analysts Covering DOCS
1 Year
1 Year Success Rate
5/15 ratings generated profit
1 Year Average Return
+38.23%
reiterated a buy rating 4 days ago
Copying Vikram Kesavabhotla's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of +38.23% per trade.
---